Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0011849 (diabetes)
 277,896 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

As there is a significant deterioration in the overall quality of life, i.e., a disruption in the professional and social life of migraine-prone subjects, it was decided that a study should be carried out to investigate this issue via specific and non-specific questionnaires. An analysis of the findings showed disturbances not only during but between migraine attacks, with evasive behavior patterns and relational problems. Current drug therapy does little to provide relief apart from the triptan group of drugs, which can be used in emergency situations, and the scores recorded for migraine are frequently noticeably lower than those for other chronic diseases such as diabetes, arthritis, or depressive disorders.
 ...
PMID:[Migraine and quality of life]. 1107 46

Profound knowledge of the different activities and side effects of the various types and combinations of HRT regimens is of paramount importance for counseling peri- and postmenopausal women. In this article some practical aspects of different topics concerning HRT such as influence of HRT on blood sugar, diabetes, blood pressure, hypertension, serum lipids, migraine, and progestin intolerance are discussed.
 ...
PMID:[Hormone replacement: side effects and problems]. 1108 76

Calcitonin gene-related peptide (CGRP), a potent vasodilatory and cardiotonic peptide, has a potential role for CGRP in diverse physiologic and pathophysiologic situations such as congestive heart failure, diabetes, migraine, and neurogenic inflammation. Although a peptide CGRP receptor antagonist, CGRP(8-37,) is available, its utility presents significant limitations for these indications. Here, we describe the properties of SB-(+)-273779 [N-methyl-N-(2-methylphenyl)-3-nitro-4-(2-thiazolylsulfinyl)nitrobenzanilide], a selective nonpeptide antagonist of CGRP(1) receptor. SB-(+)-273779 inhibited (125)I-labeled CGRP binding to SK-N-MC (human neuroblastoma cells) and human cloned CGRP(1) receptor with K(i) values of 310 +/- 40 and 250 +/-15 nM, respectively. SB-(+)-273779 also inhibited CGRP (3 nM)-activated adenylyl cyclase in these systems with IC(50) values of 390 +/-10 nM (in SK-N-MC) and 210 +/-16 nM (recombinant human CGRP receptors). Prolonged treatment (>30 min) of SK-N-MC cells with SB-(+)-273779 followed by extensive washing resulted in reduction in maximum CGRP-mediated adenylyl cyclase activity, suggesting that this compound has irreversible binding characteristics. In addition, SB-(+)-273779 antagonized CGRP-mediated 1) stimulation of intracellular Ca(2+) in recombinant CGRP receptors in HEK-293 cells, 2) inhibition of insulin-stimulated [(14)C]deoxyglucose uptake in L6 cells, 3) vasodilation in rat pulmonary artery, and 4) decrease in blood pressure in anesthetized rats. SB-(+)-273779 tested at 3 microM had no significant affinity for calcitonin, endothelin, angiotensin II, and alpha-adrenergic receptors under standard ligand binding assays. SB-(+)-273779 also did not inhibit forskolin and pituitary adenylate cyclase-activating polypeptide. These results suggest that SB-(+)-273779 is a valuable tool for studying CGRP-mediated functional responses in complex biological systems.
 ...
PMID:Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist. 1118 5

A representative, prospective population sample of 1,205 7-year-old children in a larger Finnish city was followed for 15 years for headache and other medical disorders and symptoms. The comorbidity associated with headache was found to be higher than expected. Allergy and bronchial asthma, diabetes mellitus and stomachache were more common in boys than in girls, while psychiatric symptoms and sleep disturbances were more typical of girls than boys. The prevalence rate of any headache and migraine increases up to the age of 13 years, but after that age, a decline in the prevalence is found in boys, while girls show an increasing trend both in the presence and in the frequency of any headache and migraine.
 ...
PMID:Headache in teenagers: comorbidity and prognosis. 1120 Jul 81

Disease management is a comprehensive approach to improving the outcomes for patients suffering from chronic disease. It has frequently been applied to diseases like diabetes and asthma but, to date, has not widely been regarded as particularly relevant to migraine. Yet a number of factors suggest that this view might usefully be reconsidered, notably the dissatisfaction with migraine control expressed by many patients and the inconsistencies in treatment patterns observed across clinical practice. Another factor is the growing range of therapeutic options available to manage the disorder. In this latter respect, decision-making must not only be governed by individual patient needs, but also by considerations of clinical cost effectiveness. Pharmacoeconomic analysis can play a useful role in determining the relative value for money offered by different treatments and is increasingly being applied in migraine. It is clear, however, that full realisation of its potential contribution requires progress to be made in a number of key areas, perhaps most importantly agreement on the definition of successful treatment.
 ...
PMID:The relevance and application of disease management and pharmacoeconomics to migraine. 1120 Jul 94

Menstrual cycle-related exacerbation of common medical conditions such as migraine, epilepsy, asthma, irritable bowel syndrome, and diabetes, is a well-recognized phenomenon. Accurate documentation of symptoms on a menstrual calendar allows identification of women with cyclic alterations in disease activity.
 ...
PMID:Menstrual cycle effects on common medical conditions. 1128 Aug 58

Even though Mg is by far the least abundant serum electrolyte, it is extremely important for the metabolism of Ca, K, P, Zn, Cu, Fe, Na, Pb, Cd, HCl, acetylcholine, and nitric oxide (NO), for many enzymes, for the intracellular homeostasis and for activation of thiamine and therefore, for a very wide gamut of crucial body functions. Unfortunately, Mg absorption and elimination depend on a very large number of variables, at least one of which often goes awry, leading to a Mg deficiency that can present with many signs and symptoms. Mg absorption requires plenty of Mg in the diet, Se, parathyroid hormone (PTH) and vitamins B6 and D. Furthermore, it is hindered by excess fat. On the other hand, Mg levels are decreased by excess ethanol, salt, phosphoric acid (sodas) and coffee intake, by profuse sweating, by intense, prolonged stress, by excessive menstruation and vaginal flux, by diuretics and other drugs and by certain parasites (pinworms). The very small probability that all the variables affecting Mg levels will behave favorably, results in a high probability of a gradually intensifying Mg deficiency. It is highly regrettable that the deficiency of such an inexpensive, low-toxicity nutrient result in diseases that cause incalculable suffering and expense throughout the world. The range of pathologies associated with Mg deficiency is staggering: hypertension (cardiovascular disease, kidney and liver damage, etc.), peroxynitrite damage (migraine, multiple sclerosis, glaucoma, Alzheimer's disease, etc.), recurrent bacterial infection due to low levels of nitric oxide in the cavities (sinuses, vagina, middle ear, lungs, throat, etc.), fungal infections due to a depressed immune system, thiamine deactivation (low gastric acid, behavioral disorders, etc.), premenstrual syndrome, Ca deficiency (osteoporosis, hypertension, mood swings, etc.), tooth cavities, hearing loss, diabetes type II, cramps, muscle weakness, impotence (lack of NO), aggression (lack of NO), fibromas, K deficiency (arrhythmia, hypertension, some forms of cancer), Fe accumulation, etc. Finally, because there are so many variables involved in the Mg metabolism, evaluating the effect of Mg in many diseases has frustrated many researchers who have simply tried supplementation with Mg, without undertaking the task of ensuring its absorption and preventing excessive elimination, rendering the study of Mg deficiency much more difficult than for most other nutrients.
 ...
PMID:The multifaceted and widespread pathology of magnesium deficiency. 1142 81

Stroke patients have a high recurrence risk of 4-14% per year--depending on individual etiology. The best way of preventing a repeat insult and protecting the patient's remaining quality of life is to rigorously apply all available secondary prophylactic possibilities. These include measures aimed at modifying a health-endangering lifestyle, as well as medical treatment of all risk-enhancing illnesses. The present article offers an overview of the major confirmed and modifiable risk factors for stroke (arterial hypertension, smoking, atrial fibrillation, diabetes mellitus, overweight, hyper-cholesterolemia, thrombophilia, immoderate use of alcohol, lack of exercise, use of contraceptives, migraine), and outlines therapeutic strategies for secondary prevention.
 ...
PMID:[Stroke patients in general practice. Preventing recurrent infarct]. 1143 56

To clarify the characteristics of CADASIL in Japan, we performed clinical and genetic investigations for six patients from 5 Japanese families diagnosed as CADASIL. We identified that the onset of focal neurologic deficits ranged from 38 to 63 years old (mean 49 +/- 9.4 yrs) and the occurrence rates of main neurologic symptoms and signs were 1/6 for migraine, 3/6 for recurrent stroke episodes, 6/6 for dementia, and 4/6 for pseudobulbar palsy. The marked narrowing of retinal arteries were observed in 3/6. The notch 3 mutations were all found in exon 4. Although other several families shared similar phenotype of CADASIL, there were no deposition of granular osmiophilic materials within the basal lamina of smooth muscle cells in the arterioles of biopsied muscle and no mutations in the cording regions of notch 3 gene. We investigated prospectively the incidence of CADASIL and CADASIL-like disease in Kumamoto district from 1999 to 2000. One thousand and thirty four patients with stroke were hospitalized in 6 hospitals which have stroke care unit. Among them, 7 patients fulfilled the criteria that were less than 60 years old, lacunar strokes and/or TIA, presence of a family history, and no risk factors such as hypertension, diabetes mellitus, and hyperlipidemia. One of seven patients was diagnosed as CADASIL by DNA analysis. It was suspected the incidences of CADASIL and CADASIL-like disease were not so rare in Japan.
 ...
PMID:[CADASIL: clinical analysis of CADASIL and CADASIL-like disorders in Japan]. 1146 69

Nutrition support in gastroparesis begins with encouraging smaller volume, low-fat, low-fiber meals and, if necessary, liquid caloric supplements. There should be a low threshold for placing a jejunal feeding tube either by laparoscopy or mini-laparotomy. Parenteral nutrition should be used only briefly during hospitalization and not encouraged or sustained as an outpatient. Metoclopramide is now the prokinetic of choice for patients who can tolerate this agent; subcutaneous administration is an important method that allows for continued guaranteed absorption. Low-dosage erythromycin also has a prokinetic role alone or in combination with metoclopramide. Domperidone, a centrally acting antiemetic and prokinetic, is only be available to US citizens who can access sources in Canada or Mexico. Antiemetics should be used extensively because nausea is a very severe debilitating symptom, which is under-appreciated and under-treated by physicians. We recommend scopolamine patches to gain maximal absorption, in spite of vomiting and unpredictable oral intakes. The 5-hydroxytryptamine-3 (5-HT3) antagonists ondansetron and granisetron are the most powerful agents. Relief bands using the P6 acupuncture point are useful adjunct. Special vigilance should be paid to situations that can undermine medical therapy or result in breakthrough symptoms, such as hyperglycemic events in patients with diabetes, migraine headaches, cyclic nausea and vomiting, menstrual cycles, rumination syndrome (psychogenic vomiting), and elevated herpes simplex titers. Most excitingly, the era of gastric electrical stimulation has arrived for patients not responding to standard medical therapy. The dramatic improvement in nausea and vomiting, as well as a sustained evidence of improved quality of life, gastric emptying, nutritional status, and decreased hospitalizations by this device are documented by long-term follow-up of more than a year for patients in this country and world-wide.
 ...
PMID:Gastric Dysmotility and Gastroparesis. 1146 76


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>